Dr. Martens Plc

As of March 31, 2026, DR MARTENS PLC carries a market capitalization of 799.34M, placing it among publicly traded companies globally. Its enterprise value stands at 1.08B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

DR MARTENS PLC's next confirmed earnings release is scheduled for November 26, 2026.

As of March 31, 2026, DR MARTENS PLC has 956.62M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, DR MARTENS PLC maintains a current ratio of 2.61, meaning it holds 2.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, DR MARTENS PLC's stock has declined approximately 31.17% over the past 52 weeks. The 50-day moving average sits at 0.94, while the 200-day moving average is 0.95.

As of March 31, 2026, DR MARTENS PLC holds 238.45M in cash and equivalents against 520.40M in total debt, resulting in a net debt position of 91.78M. Total book value stands at 478.08M, with working capital of 340.15M providing operational flexibility.